Terms: = Liver cancer AND CARS, P49589, 833, ENSG00000110619 AND Treatment
66 results:
1. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast.
Wang Y; Li Y; Jiang H; Zuo C; Xu W
Br J Radiol; 2024 Jan; 97(1153):237-248. PubMed ID: 38263821
[TBL] [Abstract] [Full Text] [Related]
2. Sarcopenia affects the clinical efficacy of immune checkpoint inhibitors in patients with gastrointestinal cancers.
Lilong Z; Kuang T; Li M; Li X; Hu P; Deng W; Wang W
Clin Nutr; 2024 Jan; 43(1):31-41. PubMed ID: 38000193
[TBL] [Abstract] [Full Text] [Related]
3. Nomogram to predict liver surgery-specific complications for hepatocellular carcinoma: A multicenter study.
Qi W; Dai J; Qiu Z; Wu Y; Wen T; Xie F; Gao F; Zhang Y; Li C
Eur J Surg Oncol; 2023 Dec; 49(12):107119. PubMed ID: 37871467
[TBL] [Abstract] [Full Text] [Related]
4. HGF-Based CAR-T Cells Target Hepatocellular Carcinoma Cells That Express High Levels of c-Met.
Ma H; Wei W; Liang D; Xu X; Yang D; Wang Q; Wang Y; Wei Q; Sun B; Zhao X
Immunol Invest; 2023 Nov; 52(6):735-748. PubMed ID: 37409941
[TBL] [Abstract] [Full Text] [Related]
5. Risk factors for irinotecan-induced liver injury: a retrospective multicentre cross-sectional study in China.
Han J; Liu J; Yu Z; Huang R; Zhao L; Xu Y; Chen M; He G; Song Q; Li W; Zhang C
BMJ Open; 2023 Jun; 13(6):e069794. PubMed ID: 37349101
[TBL] [Abstract] [Full Text] [Related]
6. Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report.
Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
[TBL] [Abstract] [Full Text] [Related]
7. MRI-based radiomics model and nomogram for predicting the outcome of locoregional treatment in patients with hepatocellular carcinoma.
Wang Y; Liu Z; Xu H; Yang D; Jiang J; Asayo H; Yang Z
BMC Med Imaging; 2023 May; 23(1):67. PubMed ID: 37254089
[TBL] [Abstract] [Full Text] [Related]
8. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers.
Sun J; Hu S; Li X
Biomarkers; 2023 Sep; 28(6):477-485. PubMed ID: 37017446
[TBL] [Abstract] [Full Text] [Related]
9. A Novel and Simplified Score for Determining treatment Eligibility for Patients with Chronic Hepatitis B.
Geeratragool T; Tangkijvanich P; Nimanong S; Chainuvati S; Charatcharoenwitthaya P; Tanwandee T; Chotiyaputta W
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992433
[No Abstract] [Full Text] [Related]
10. Computed tomography texture analysis combined with preoperative clinical factors serve as a predictor of early efficacy of transcatheter arterial chemoembolization in hepatocellular carcinoma.
Fan XL; Wang YH; Chen YH; Chen BX; Cai JN; Yang JS; Sun X; Yan FR; He BS
Abdom Radiol (NY); 2023 Jun; 48(6):2008-2018. PubMed ID: 36943423
[TBL] [Abstract] [Full Text] [Related]
11. Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M; Giommoni E; Bergamo F; Milella M; Cavanna L; Di Marco MC; Spada M; Cordio S; Aprile G; Cardellino GG; Maiello E; Bernardini I; Ghidini M; Bozzarelli S; Macchini M; Orsi G; De Simone I; Rulli E; Porcu L; Torri V; Pinto C;
ESMO Open; 2023 Feb; 8(1):100777. PubMed ID: 36731325
[TBL] [Abstract] [Full Text] [Related]
12. Machine learning approaches for prediction of early death among lung cancer patients with bone metastases using routine clinical characteristics: An analysis of 19,887 patients.
Cui Y; Shi X; Wang S; Qin Y; Wang B; Che X; Lei M
Front Public Health; 2022; 10():1019168. PubMed ID: 36276398
[TBL] [Abstract] [Full Text] [Related]
13. Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
Kaneko S; Kurosaki M; Mashiba T; Marusawa H; Kondo M; Kojima Y; Uchida Y; Fujii H; Akahane T; Yagisawa H; Kusakabe A; Kobashi H; Abe T; Yoshida H; Ogawa C; Furuta K; Tamaki N; Tsuji K; Matsushita T; Izumi N;
J Med Virol; 2023 Jan; 95(1):e28210. PubMed ID: 36222204
[TBL] [Abstract] [Full Text] [Related]
14. Immunotherapy for hepatobiliary cancers: Emerging targets and translational advances.
Li D; Lin S; Hong J; Ho M
Adv Cancer Res; 2022; 156():415-449. PubMed ID: 35961708
[TBL] [Abstract] [Full Text] [Related]
15. Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure.
Lin X; Song A; Lu J; Zheng S; Hu Z; Ma L; Cao Z; Li H; Zheng Y; Ren S; Chen X
Front Immunol; 2022; 13():879835. PubMed ID: 35860247
[TBL] [Abstract] [Full Text] [Related]
16. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies.
Antonucci L; Canciani G; Mastronuzzi A; Carai A; Del Baldo G; Del Bufalo F
Front Immunol; 2022; 13():867154. PubMed ID: 35603195
[TBL] [Abstract] [Full Text] [Related]
17. Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).
Brugel M; Letrillart L; Evrard C; Thierry A; Tougeron D; El Amrani M; Piessen G; Truant S; Turpin A; d'Engremont C; Roth G; Hautefeuille V; Regimbeau JM; Williet N; Schwarz L; Di Fiore F; Borg C; Doussot A; Lambert A; Moulin V; Trelohan H; Bolliet M; Topolscki A; Ayav A; Lopez A; Botsen D; Piardi T; Carlier C; Bouché O
Eur J Cancer; 2022 May; 166():8-20. PubMed ID: 35259629
[TBL] [Abstract] [Full Text] [Related]
18. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.
Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of Survival Outcomes in Transarterial Ethanol Ablation and liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by liver Function.
Yu SCH; Hui JWY; Chong CCN; Cho CCM; Cheung S; Wong J; Lee KF
Cardiovasc Intervent Radiol; 2022 Mar; 45(3):315-327. PubMed ID: 34609579
[TBL] [Abstract] [Full Text] [Related]
20. Distal pancreatectomy with resection of the celiac trunk, right or left hepatic artery without arterial reconstruction (extended DP-CAR).
Egorov VI; Petrov RV; Amosova EL; Kharazov AF; Petrov KS; Zhurina YA; Kondratyev EV; Zelter PM; Dzigasov SO; Grigorievsky MV
Khirurgiia (Mosk); 2021; (10):13-28. PubMed ID: 34608776
[TBL] [Abstract] [Full Text] [Related]
[Next]
